{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:43:14Z","timestamp":1793227394271,"version":"4.5.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"DOI":"10.1007\/s12011-026-05252-w","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:28:33Z","timestamp":1784878113000},"page":"8196-8213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recent Advances in the Treatment of Thyroid Pathologies with Selenium-Containing Compounds, Nanoparticles and Nanocomplexes Based on Selenium and Selenoproteins"],"prefix":"10.1007","volume":"204","author":[{"given":"Elena G.","family":"Varlamova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"1","key":"5252_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s42000-019-00150-4","volume":"19","author":"L Schomburg","year":"2020","unstructured":"Schomburg L (2020) The other view: the trace element selenium as a micronutrient in thyroid disease, diabetes, and beyond. Horm (Athens) 19(1):15\u201324. https:\/\/doi.org\/10.1007\/s42000-019-00150-4","journal-title":"Horm (Athens)"},{"issue":"5","key":"5252_CR2","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/nu12051337","volume":"12","author":"S Benvenga","year":"2020","unstructured":"Benvenga S, Ferrari SM, Elia G, Ragusa F, Patrizio A, Paparo SR, Camastra S, Bonofiglio D, Antonelli A, Fallahi P (2020) Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies. Nutrients 12(5):1337. https:\/\/doi.org\/10.3390\/nu12051337","journal-title":"Nutrients"},{"issue":"1","key":"5252_CR3","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.beem.2020.101377","volume":"34","author":"S Benvenga","year":"2020","unstructured":"Benvenga S, Elia G, Ragusa F, Paparo SR, Sturniolo MM, Ferrari SM, Antonelli A, Fallahi P (2020) Endocrine disruptors and thyroid autoimmunity. Best Pract Res Clin Endocrinol Metab 34(1):101377. https:\/\/doi.org\/10.1016\/j.beem.2020.101377","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"5252_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3275\/8579","volume":"36","author":"F Boi","year":"2013","unstructured":"Boi F, Minerba L, Lai ML, Marziani B, Figus B, Spanu F, Borghero A, Mariotti S (2013) Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules. J Endocrinol Invest 36(5):313\u2013320. https:\/\/doi.org\/10.3275\/8579","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"5252_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-2265.2011.04318.x","volume":"76","author":"TH Brix","year":"2012","unstructured":"Brix TH, Heged\u00fcs L (2012) Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf) 76(4):457\u2013464. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04318.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5252_CR6","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Gol\u2019tiaev MV, Novocelov SV, Novoselov VI, Fecenko EE (2013) Biosyinthesis and mechanism of selenocysteine incorporation into synthesized proteins. Mol Biol (Mosk) Russian 47(4):558\u201367. https:\/\/doi.org\/10.7868\/s0026898413040137","DOI":"10.7868\/s0026898413040137"},{"key":"5252_CR7","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Gol\u2019tiaev MV, Novoselov SV, Novoselov VI, Fecenko EE (2013) Characterization of some thiol oxidoreductase family members. Mol Biol (Mosk) Russian 47(4):568\u201382. https:\/\/doi.org\/10.7868\/s0026898413040149","DOI":"10.7868\/s0026898413040149"},{"key":"5252_CR8","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Novoselov SV (2016 Jan-Feb) [Methods to Biosynthesize Mammalian Selenocysteine-Containing Proteins in vitro]. Mol Biol (Mosk) 50(1):44\u201350 Russian. https:\/\/doi.org\/10.7868\/S0026898416010213","DOI":"10.7868\/S0026898416010213"},{"issue":"1","key":"5252_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1134\/S1607672916030121","volume":"468","author":"EG Varlamova","year":"2016","unstructured":"Varlamova EG, Goltyaev MV, Fesenko EE (2016) Expression of human selenoprotein genes selh, selk, selm, sels, selv, and gpx-6 in various tumor cell lines. Dokl Biochem Biophys 468(1):203\u2013205. https:\/\/doi.org\/10.1134\/S1607672916030121","journal-title":"Dokl Biochem Biophys"},{"issue":"1","key":"5252_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1134\/S160767291705012X","volume":"476","author":"EG Varlamova","year":"2017","unstructured":"Varlamova EG, Goltyaev MV, Novoselov VI, Fesenko EE (2017) Cloning, intracellular localization, and expression of the mammalian selenocysteine-containing protein SELENOI (SelI) in tumor cell lines. Dokl Biochem Biophys 476(1):320\u2013322. https:\/\/doi.org\/10.1134\/S160767291705012X","journal-title":"Dokl Biochem Biophys"},{"issue":"1","key":"5252_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1134\/S1607672919050065","volume":"488","author":"EG Varlamova","year":"2019","unstructured":"Varlamova EG, Goltyaev MV, Fesenko EE (2019) Protein Partners of Selenoprotein SELM and the Role of Selenium Compounds in Regulation of Its Expression in Human Cancer Cells. Dokl Biochem Biophys 488(1):300\u2013303. https:\/\/doi.org\/10.1134\/S1607672919050065","journal-title":"Dokl Biochem Biophys"},{"key":"5252_CR12","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Novoselov SV, Novoselov VI, Fesenko EE (2011 Nov-Dec) New mammalian selenium-containing protein V: the search for protein partners. Dokl Biochem Biophys 441:255\u2013257. https:\/\/doi.org\/10.1134\/S1607672911060056","DOI":"10.1134\/S1607672911060056"},{"key":"5252_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jtemb.2016.08.004","volume":"39","author":"EG Varlamova","year":"2017","unstructured":"Varlamova EG, Cheremushkina IV (2017) Contribution of mammalian selenocysteine-containing proteins to carcinogenesis. J Trace Elem Med Biol 39:76\u201385. https:\/\/doi.org\/10.1016\/j.jtemb.2016.08.004","journal-title":"J Trace Elem Med Biol"},{"key":"5252_CR14","doi-asserted-by":"publisher","first-page":"110344","DOI":"10.1016\/j.abb.2025.110344","volume":"766","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG (2025) Roles of selenium-containing glutathione peroxidases and thioredoxin reductases in the regulation of processes associated with glioblastoma progression. Arch Biochem Biophys 766:110344. https:\/\/doi.org\/10.1016\/j.abb.2025.110344","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"5252_CR15","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1210\/jc.2010-2905","volume":"96","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Di Domenicantonio A, Nicolini A, Ferrari P, Ferrannini E, Fallahi P (2011) Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 96(6):1859\u20131863. https:\/\/doi.org\/10.1210\/jc.2010-2905","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 4","key":"5252_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/0004563216642255","volume":"53","author":"V Eligar","year":"2016","unstructured":"Eligar V, Taylor PN, Okosieme OE, Leese GP, Dayan CM (2016) Thyroxine replacement: a clinical endocrinologist\u2019s viewpoint. Ann Clin Biochem 53(Pt 4):421\u2013433. https:\/\/doi.org\/10.1177\/0004563216642255","journal-title":"Ann Clin Biochem"},{"issue":"2 Suppl","key":"5252_CR17","first-page":"36","volume":"21","author":"SM Ferrari","year":"2017","unstructured":"Ferrari SM, Fallahi P, Di Bari F, Vita R, Benvenga S, Antonelli A (2017) Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis. Eur Rev Med Pharmacol Sci 21(2 Suppl):36\u201342","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5 Pt 1","key":"5252_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-139-5_part_1-200309020-00010","volume":"139","author":"L Chiovato","year":"2003","unstructured":"Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A (2003) Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139(5 Pt 1):346\u2013351. https:\/\/doi.org\/10.7326\/0003-4819-139-5_part_1-200309020-00010","journal-title":"Ann Intern Med"},{"issue":"4","key":"5252_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11154-018-9476-x","volume":"19","author":"SM Ferrari","year":"2018","unstructured":"Ferrari SM, Elia G, Ragusa F, Paparo SR, Caruso C, Benvenga S, Fallahi P, Antonelli A (2018) The protective effect of myo-inositol on human thyrocytes. Rev Endocr Metab Disord 19(4):355\u2013362. https:\/\/doi.org\/10.1007\/s11154-018-9476-x","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"5252_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.autrev.2018.10.001","volume":"18","author":"SM Ferrari","year":"2019","unstructured":"Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Benvenga S, Antonelli A (2019) The association of other autoimmune diseases in patients with Graves\u2019 disease (with or without ophthalmopathy): Review of the literature and report of a large series. Autoimmun Rev 18(3):287\u2013292. https:\/\/doi.org\/10.1016\/j.autrev.2018.10.001","journal-title":"Autoimmun Rev"},{"issue":"18","key":"5252_CR21","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.3390\/ijms20184413","volume":"20","author":"SM Ferrari","year":"2019","unstructured":"Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Varricchi G, Marone G, Antonelli A (2019) Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. Int J Mol Sci 20(18):4413. https:\/\/doi.org\/10.3390\/ijms20184413","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5252_CR22","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.beem.2019.101366","volume":"34","author":"SM Ferrari","year":"2020","unstructured":"Ferrari SM, Fallahi P, Elia G, Ragusa F, Camastra S, Paparo SR, Giusti C, Gonnella D, Ruffilli I, Shoenfeld Y, Antonelli A (2020) Novel therapies for thyroid autoimmune diseases: An update. Best Pract Res Clin Endocrinol Metab 34(1):101366. https:\/\/doi.org\/10.1016\/j.beem.2019.101366","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"5252_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1530\/EJE-10-1026","volume":"164","author":"LB Rasmussen","year":"2011","unstructured":"Rasmussen LB, Schomburg L, K\u00f6hrle J, Pedersen IB, Hollenbach B, H\u00f6g A, Ovesen L, Perrild H, Laurberg P (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur J Endocrinol 164(4):585\u2013590. https:\/\/doi.org\/10.1530\/EJE-10-1026","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"5252_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1530\/eje.0.1480309","volume":"148","author":"H Derumeaux","year":"2003","unstructured":"Derumeaux H, Valeix P, Castetbon K, Bensimon M, Boutron-Ruault MC, Arnaud J, Hercberg S (2003) Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur J Endocrinol 148(3):309\u2013315. https:\/\/doi.org\/10.1530\/eje.0.1480309","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"5252_CR25","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1210\/jc.2015-2222","volume":"100","author":"Q Wu","year":"2015","unstructured":"Wu Q, Rayman MP, Lv H, Schomburg L, Cui B, Gao C, Chen P, Zhuang G, Zhang Z, Peng X, Li H, Zhao Y, He X, Zeng G, Qin F, Hou P, Shi B (2015) Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease. J Clin Endocrinol Metab 100(11):4037\u20134047. https:\/\/doi.org\/10.1210\/jc.2015-2222","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"5252_CR26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/biom15091336","volume":"15","author":"EA Turovsky","year":"2025","unstructured":"Turovsky EA, Gudkov SV, Varlamova EG (2025) Therapeutic Effect of Selenium Nanoparticles, Sorafenib, and Selenium-Sorafenib Nanocomplex in the Lungs and Kidneys of Mice with TAA-Induced HCC. Biomolecules 15(9):1336. https:\/\/doi.org\/10.3390\/biom15091336","journal-title":"Biomolecules"},{"key":"5252_CR27","doi-asserted-by":"publisher","first-page":"127620","DOI":"10.1016\/j.jtemb.2025.127620","volume":"88","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG (2025) Selenium-containing compounds, selenium nanoparticles and selenoproteins in the prevention and treatment of lung cancer. J Trace Elem Med Biol 88:127620. https:\/\/doi.org\/10.1016\/j.jtemb.2025.127620","journal-title":"J Trace Elem Med Biol"},{"key":"5252_CR28","doi-asserted-by":"publisher","first-page":"151962","DOI":"10.1016\/j.bbrc.2025.151962","volume":"769","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG, Gudkov SV, Blinova EV, Blinov DS, Turovsky EA (2025) Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model. Biochem Biophys Res Commun 769:151962. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151962","journal-title":"Biochem Biophys Res Commun"},{"key":"5252_CR29","doi-asserted-by":"publisher","unstructured":"Turovsky EA, Baimler IV, Rogachev VV, Gudkov SV, Varlamova EG (2025 Dec) Selenium-Tellurium Hybrid Nanoparticles: Selectivity, Mechanisms of Redox Modulation, and Therapeutic Prospects in Oncology. Biol Trace Elem Res 23. https:\/\/doi.org\/10.1007\/s12011-025-04953-y","DOI":"10.1007\/s12011-025-04953-y"},{"key":"5252_CR30","doi-asserted-by":"publisher","unstructured":"Varlamova EG (2026 Feb) Selenium-Containing Compounds in Breast Cancer Therapy. Biol Trace Elem Res 13. https:\/\/doi.org\/10.1007\/s12011-026-05026-4","DOI":"10.1007\/s12011-026-05026-4"},{"issue":"1","key":"5252_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12011-025-04682-2","volume":"204","author":"EG Varlamova","year":"2026","unstructured":"Varlamova EG, Gudkov SV, Turovsky EA (2026) Opposite Effects of Small and Large Diameter Selenium Nanoparticles on the Redox-Status and Survival of Cortical Cells in Toxic Models In Vitro. Biol Trace Elem Res 204(1):300\u2013321. https:\/\/doi.org\/10.1007\/s12011-025-04682-2","journal-title":"Biol Trace Elem Res"},{"issue":"8","key":"5252_CR32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/biology10080743","volume":"10","author":"EA Turovsky","year":"2021","unstructured":"Turovsky EA, Varlamova EG (2021) Mechanism of Ca2+-Dependent Pro-Apoptotic Action of Selenium Nanoparticles, Mediated by Activation of Cx43 Hemichannels. Biology (Basel) 10(8):743. https:\/\/doi.org\/10.3390\/biology10080743","journal-title":"Biology (Basel)"},{"issue":"15","key":"5252_CR33","doi-asserted-by":"publisher","first-page":"8095","DOI":"10.3390\/ijms22158095","volume":"22","author":"EA Turovsky","year":"2021","unstructured":"Turovsky EA, Varlamova EG, Turovskaya MV (2021) Activation of Cx43 Hemichannels Induces the Generation of Ca2\u2009+\u2009Oscillations in White Adipocytes and Stimulates Lipolysis. Int J Mol Sci 22(15):8095. https:\/\/doi.org\/10.3390\/ijms22158095","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5252_CR34","doi-asserted-by":"publisher","first-page":"e1907568","DOI":"10.1002\/adma.201907568","volume":"32","author":"S Gao","year":"2020","unstructured":"Gao S, Li T, Guo Y, Sun C, Xianyu B, Xu H (2020) Selenium-Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy. Adv Mater 32(12):e1907568. https:\/\/doi.org\/10.1002\/adma.201907568","journal-title":"Adv Mater"},{"issue":"13","key":"5252_CR35","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.3390\/ijms23137464","volume":"23","author":"EG Varlamova","year":"2022","unstructured":"Varlamova EG, Gudkov SV, Plotnikov EY, Turovsky EA (2022) Size-Dependent Cytoprotective Effects of Selenium Nanoparticles during Oxygen-Glucose Deprivation in Brain Cortical Cells. Int J Mol Sci 23(13):7464. https:\/\/doi.org\/10.3390\/ijms23137464","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5252_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.31661\/jbpe.v0i0.2502-1887","volume":"16","author":"F Mortazavi","year":"2026","unstructured":"Mortazavi F, Tamaddon P, Ketabi A, Haghighi H, Khajeheian K, Haghani M, Mahmoudi T, Masjoodi S, Negahdary M, Sattarahmady N (2026) Selenium-Curcumin-PEG Nanoparticles Radiosensitization for Intensity-Modulated Radiation Therapy of Lung Tumor Cells: In Vitro Synergistic Combination Therapy. J Biomed Phys Eng 16(1):11\u201320. https:\/\/doi.org\/10.31661\/jbpe.v0i0.2502-1887","journal-title":"J Biomed Phys Eng"},{"key":"5252_CR37","doi-asserted-by":"publisher","unstructured":"Gao Y, Yang F, Yin L, Wang W, Wang K, Zhang H, Zhang Z, Chen D, Pan K, Liu W, Jia B, Xu C, Cao Z, Chen A, Pei D, Xiao H, Shao Z, Xing N (2026 Mar) A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer. ACS Nano 10. https:\/\/doi.org\/10.1021\/acsnano.5c21831","DOI":"10.1021\/acsnano.5c21831"},{"key":"5252_CR38","doi-asserted-by":"publisher","unstructured":"Novin MG, Novin MG, Abdollahifar MA, Raee P, Moradi A, Mosleh H, Nazarian H, Mofarahe ZS (2026 Jan) Effects of quercetin-loaded nanoselenium on spermatogenesis in a mouse model of cyclophosphamide-induced testicular damage. Clin Exp Reprod Med 5. https:\/\/doi.org\/10.5653\/cerm.2025.07801","DOI":"10.5653\/cerm.2025.07801"},{"issue":"11","key":"5252_CR39","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.3390\/pharmaceutics14112477","volume":"14","author":"EG Varlamova","year":"2022","unstructured":"Varlamova EG, Khabatova VV, Gudkov SV, Plotnikov EY, Turovsky EA (2022) Cytoprotective Properties of a New Nanocomplex of Selenium with Taxifolin in the Cells of the Cerebral Cortex Exposed to Ischemia\/Reoxygenation. Pharmaceutics 14(11):2477. https:\/\/doi.org\/10.3390\/pharmaceutics14112477","journal-title":"Pharmaceutics"},{"key":"5252_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nut.2018.05.022","volume":"57","author":"M Molanouri Shamsi","year":"2019","unstructured":"Molanouri Shamsi M, Chekachak S, Soudi S, Gharakhanlou R, Quinn LS, Ranjbar K, Rezaei S, Shirazi FJ, Allahmoradi B, Yazdi MH, Mahdavi M, Voltarelli FA (2019) Effects of exercise training and supplementation with selenium nanoparticle on T-helper 1 and 2 and cytokine levels in tumor tissue of mice bearing the 4 T1 mammary carcinoma. Nutrition 57:141\u2013147. https:\/\/doi.org\/10.1016\/j.nut.2018.05.022","journal-title":"Nutrition"},{"issue":"7","key":"5252_CR41","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1021\/acs.jafc.5c16705","volume":"74","author":"X Tian","year":"2026","unstructured":"Tian X, Chen H, Ren D, Yang X (2026) Selenium Nanoparticles Driving Innovations across the Food Chain: Applications in Food Systems, Feed Supplementation, and Sustainable Agriculture. J Agric Food Chem 74(7):5941\u20135961. https:\/\/doi.org\/10.1021\/acs.jafc.5c16705","journal-title":"J Agric Food Chem"},{"issue":"2","key":"5252_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11259-025-11026-x","volume":"50","author":"AM Elbaz","year":"2026","unstructured":"Elbaz AM, Farrag B, Farag BF, Abdel-Moneim AE (2026) Effects of supplementing with Nigella sativa meal and selenium nano-particles on growth performance, immunity, microbial count, oxidative stability, and intestinal integrity-related gene expression in heat-stressed growing rabbits. Vet Res Commun 50(2):125. https:\/\/doi.org\/10.1007\/s11259-025-11026-x","journal-title":"Vet Res Commun"},{"key":"5252_CR43","doi-asserted-by":"publisher","unstructured":"Zheng N, Ma Q, Zhang R, Zhang J, Wang Q, He Y, Yang B, Steiger S, He L, Liu S (2026) Dual Therapeutic Effects of Ultra-Small Platinum-Selenium Nanoparticles on Oxalate-Induced Acute Kidney Injury. Small 7:e14825. https:\/\/doi.org\/10.1002\/smll.202514825","DOI":"10.1002\/smll.202514825"},{"issue":"17","key":"5252_CR44","doi-asserted-by":"publisher","first-page":"e2415818","DOI":"10.1002\/adma.202415818","volume":"37","author":"Y Yu","year":"2025","unstructured":"Yu Y, Xie B, Wang J, Luo W, Yang M, Xiong Z, Huang G, Yang J, Tang Z, Qiao R, Yuan Z, He L, Chen T (2025) Translational Selenium Nanoparticles Promotes Clinical Non-small-cell Lung Cancer Chemotherapy via Activating Selenoprotein-driven Immune Manipulation. Adv Mater 37(17):e2415818. https:\/\/doi.org\/10.1002\/adma.202415818","journal-title":"Adv Mater"},{"issue":"1","key":"5252_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13048-025-01825-w","volume":"18","author":"G Liu","year":"2025","unstructured":"Liu G, Dai L, Zhang R, Jia M, Lan S, Sun X, Wang Z, Dai Y, Yang S (2025) Selenium nanoparticles mitigate Cyclophosphamide-Induced premature ovarian failures in mice by activating PI3K\/AKT signaling pathway and inhibiting ferroptosis. J Ovarian Res 18(1):257. https:\/\/doi.org\/10.1186\/s13048-025-01825-w","journal-title":"J Ovarian Res"},{"issue":"12","key":"5252_CR46","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.3390\/ijms23126641","volume":"23","author":"EG Varlamova","year":"2022","unstructured":"Varlamova EG, Goltyaev MV, Simakin AV, Gudkov SV, Turovsky EA (2022) Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, Naked Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells. Int J Mol Sci 23(12):6641. https:\/\/doi.org\/10.3390\/ijms23126641","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5252_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1134\/S1607672918030018","volume":"480","author":"YP Kuznetsova","year":"2018","unstructured":"Kuznetsova YP, Goltyaev MV, Gorbacheva OS, Novoselov SV, Varlamova EG, Fesenko EE (2018) Influence of Sodium Selenite on the mRNA Expression of the Mammalian Selenocysteine-Containing Protein Genes in Testicle and Prostate Cancer Cells. Dokl Biochem Biophys 480(1):131\u2013134. https:\/\/doi.org\/10.1134\/S1607672918030018","journal-title":"Dokl Biochem Biophys"},{"key":"5252_CR48","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Goltyaev MV, Kuznetsova JP (2018) Effect of Sodium Selenite on Gene Expression of SELF, SELW, and TGR Selenoproteins in Adenocarcinoma Cells of the Human Prostate. Mol Biol (Mosk) Russian 52(3):519\u2013526. https:\/\/doi.org\/10.7868\/S0026898418030151","DOI":"10.7868\/S0026898418030151"},{"key":"5252_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.redox.2015.09.002","volume":"6","author":"SM Wajner","year":"2015","unstructured":"Wajner SM, Rohenkohl HC, Serrano T, Maia AL (2015) Sodium selenite supplementation does not fully restore oxidative stress-induced deiodinase dysfunction: Implications for the nonthyroidal illness syndrome. Redox Biol 6:436\u2013445. https:\/\/doi.org\/10.1016\/j.redox.2015.09.002","journal-title":"Redox Biol"},{"issue":"7","key":"5252_CR50","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1089\/thy.2015.0567","volume":"26","author":"SY Lee","year":"2016","unstructured":"Lee SY, Chesdachai S, Lee MJ, He XM, Tangpricha V, Braverman LE (2016) Thyroid Function in Patients with Cystic Fibrosis: No Longer a Concern? Thyroid 26(7):875\u2013879. https:\/\/doi.org\/10.1089\/thy.2015.0567","journal-title":"Thyroid"},{"issue":"3","key":"5252_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02950797","volume":"40","author":"E Kauf","year":"1994","unstructured":"Kauf E, Dawczynski H, Jahreis G, Janitzky E, Winnefeld K (1994) Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital hypothyroidism. Biol Trace Elem Res 40(3):247\u2013253. https:\/\/doi.org\/10.1007\/BF02950797","journal-title":"Biol Trace Elem Res"},{"issue":"7","key":"5252_CR52","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/00207454.2020.1835898","volume":"132","author":"E Babur","year":"2022","unstructured":"Babur E, Can\u00f6z \u00d6, Tan B, S\u00fcer C, Dursun N (2022) Effect of sodium selenite on synaptic plasticity and neurogenesis impaired by hypothyroidism. Int J Neurosci 132(7):662\u2013672. https:\/\/doi.org\/10.1080\/00207454.2020.1835898","journal-title":"Int J Neurosci"},{"key":"5252_CR53","doi-asserted-by":"publisher","unstructured":"Kim JB, Yang EY, Woo J, Kwon H, Lim W, Moon BI Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells. In Vivo. 2020 Jan-Feb ;34(1):185\u2013190. https:\/\/doi.org\/10.21873\/invivo.11760","DOI":"10.21873\/invivo.11760"},{"issue":"3","key":"5252_CR54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/biof.1351","volume":"43","author":"IC Nettore","year":"2017","unstructured":"Nettore IC, De Nisco E, Desiderio S, Passaro C, Maione L, Negri M, Albano L, Pivonello R, Pivonello C, Portella G, Ungaro P, Colao A, Macchia PE (2017) Selenium supplementation modulates apoptotic processes in thyroid follicular cells. BioFactors 43(3):415\u2013423. https:\/\/doi.org\/10.1002\/biof.1351","journal-title":"BioFactors"},{"issue":"8","key":"5252_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.endonu.2013.07.001","volume":"60","author":"G Sturniolo","year":"2013","unstructured":"Sturniolo G, Mesa J (2013) Selenium supplementation and autoimmune thyroid diseases. Endocrinol Nutr 60(8):423\u2013426. https:\/\/doi.org\/10.1016\/j.endonu.2013.07.001","journal-title":"Endocrinol Nutr"},{"issue":"2","key":"5252_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0300-9084(89)90061-8","volume":"71","author":"A Pinchera","year":"1989","unstructured":"Pinchera A, Mariotti S, Vitti P, Marcocci C, Chiovato L, Fenzi G, Santini F (1989) Thyroid autoantigens and their relevance in the pathogenesis of thyroid autoimmunity. Biochimie 71(2):237\u2013245. https:\/\/doi.org\/10.1016\/0300-9084(89)90061-8","journal-title":"Biochimie"},{"issue":"8","key":"5252_CR57","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ncpendmet0896","volume":"4","author":"LH Duntas","year":"2008","unstructured":"Duntas LH (2008) Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 4(8):454\u2013460. https:\/\/doi.org\/10.1038\/ncpendmet0896","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"6","key":"5252_CR58","doi-asserted-by":"publisher","first-page":"CD010223","DOI":"10.1002\/14651858.CD010223.pub2","volume":"2013","author":"EJ van Zuuren","year":"2013","unstructured":"van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H (2013) Selenium supplementation for Hashimoto\u2019s thyroiditis. Cochrane Database Syst Rev 2013(6):CD010223. https:\/\/doi.org\/10.1002\/14651858.CD010223.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"5252_CR59","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.3390\/nu14142869","volume":"14","author":"J Kryczyk-Kozio\u0142","year":"2022","unstructured":"Kryczyk-Kozio\u0142 J, Prochownik E, B\u0142a\u017cewska-Gruszczyk A, S\u0142owiaczek M, Sun Q, Schomburg L, Ochab E, Bartyzel M, Zagrodzki P (2022) Assessment of the Effect of Selenium Supplementation on Production of Selected Cytokines in Women with Hashimoto\u2019s Thyroiditis. Nutrients 14(14):2869. https:\/\/doi.org\/10.3390\/nu14142869","journal-title":"Nutrients"},{"issue":"10","key":"5252_CR60","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1210\/en.2007-0126","volume":"148","author":"SH Wang","year":"2007","unstructured":"Wang SH, Van Antwerp M, Kuick R, Gauger PG, Doherty GM, Fan YY, Baker JR Jr (2007) Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology 148(10):4844\u20134852. https:\/\/doi.org\/10.1210\/en.2007-0126","journal-title":"Endocrinology"},{"issue":"10","key":"5252_CR61","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1210\/en.2007-0126","volume":"148","author":"SH Wang","year":"2007","unstructured":"Wang SH, Van Antwerp M, Kuick R, Gauger PG, Doherty GM, Fan YY, Baker JR Jr (2007) Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology 148(10):4844\u20134852. https:\/\/doi.org\/10.1210\/en.2007-0126","journal-title":"Endocrinology"},{"issue":"2","key":"5252_CR62","doi-asserted-by":"publisher","first-page":"e240444","DOI":"10.20945\/2359-4292-2024-0444","volume":"69","author":"A Yoldas","year":"2025","unstructured":"Yoldas A, Bahtiyar N, Aydemir B, Toplan S (2025) Evaluation of selenoproteins and proinflammatory cytokines in L-thyroxine-induced hyperthyroid rats: effects of selenium supplementation. Arch Endocrinol Metab 69(2):e240444. https:\/\/doi.org\/10.20945\/2359-4292-2024-0444","journal-title":"Arch Endocrinol Metab"},{"key":"5252_CR63","doi-asserted-by":"publisher","first-page":"144884","DOI":"10.1016\/j.gene.2020.144884","volume":"755","author":"MV Goltyaev","year":"2020","unstructured":"Goltyaev MV, Mal\u2019tseva VN, Varlamova EG (2020) Expression of ER-resident selenoproteins and activation of cancer cells apoptosis mechanisms under ER-stress conditions caused by methylseleninic acid. Gene 755:144884. https:\/\/doi.org\/10.1016\/j.gene.2020.144884","journal-title":"Gene"},{"issue":"12","key":"5252_CR64","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.3390\/ijms22126614","volume":"22","author":"EG Varlamova","year":"2021","unstructured":"Varlamova EG, Turovsky EA, THE MAIN CYTOTOXIC EFFECTS OF METHYLSELENINIC, ACID ON VARIOUS CANCER CELLS (2021) Int J Mol Sci 22(12):6614. https:\/\/doi.org\/10.3390\/ijms22126614","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5252_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/01635580903191569","volume":"62","author":"MA Kato","year":"2010","unstructured":"Kato MA, Finley DJ, Lubitz CC, Zhu B, Moo TA, Loeven MR, Ricci JA, Zarnegar R, Katdare M, Fahey TJ 3 (2010) Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34. Nutr Cancer 62(1):66\u201373. https:\/\/doi.org\/10.1080\/01635580903191569","journal-title":"Nutr Cancer"},{"issue":"7","key":"5252_CR66","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1101\/gad.12.7.982","volume":"12","author":"H Zinszner","year":"1998","unstructured":"Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12(7):982\u2013995. https:\/\/doi.org\/10.1101\/gad.12.7.982","journal-title":"Genes Dev"},{"issue":"2","key":"5252_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0891-5849(00)00461-5","volume":"30","author":"K Oh-Hashi","year":"2001","unstructured":"Oh-Hashi K, Maruyama W, Isobe K (2001) Peroxynitrite induces GADD34, 45, and 153 VIA p38 MAPK in human neuroblastoma SH-SY5Y cells. Free Radic Biol Med 30(2):213\u2013221. https:\/\/doi.org\/10.1016\/s0891-5849(00)00461-5","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"5252_CR68","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mnfr.200700157","volume":"52","author":"MH Pan","year":"2008","unstructured":"Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S, Ho CT (2008) 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res 52(5):527\u2013537. https:\/\/doi.org\/10.1002\/mnfr.200700157","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"5252_CR69","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/jcph.1447","volume":"59","author":"R Krysiak","year":"2019","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2019) The Effect of Selenomethionine on Thyroid Autoimmunity in Euthyroid Men With Hashimoto Thyroiditis and Testosterone Deficiency. J Clin Pharmacol 59(11):1477\u20131484. https:\/\/doi.org\/10.1002\/jcph.1447","journal-title":"J Clin Pharmacol"},{"issue":"16","key":"5252_CR70","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.2174\/0113862073286006231228070738","volume":"27","author":"R Pan","year":"2024","unstructured":"Pan R, Zhao J, Yao J, Gao Y, Liao L (2024) Selenomethionine Suppress the Progression of Poorly Differentiated Thyroid Cancer via LncRNA NONMMUT014201\/miR-6963-5p\/Srprb Pathway. Comb Chem High Throughput Screen 27(16):2419\u20132432. https:\/\/doi.org\/10.2174\/0113862073286006231228070738","journal-title":"Comb Chem High Throughput Screen"},{"issue":"12","key":"5252_CR71","doi-asserted-by":"publisher","first-page":"575","DOI":"10.5414\/CP204751","volume":"63","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zeng Y (2025) Expression of the genes QPRT, RAB26, and SRPRB in cancer tissue from patients with triple-negative breast cancer as a biomarker for diagnosis, pharmacotherapy strategy, and survival: Evidence from bioinformatic database analysis. Int J Clin Pharmacol Ther 63(12):575\u2013583. https:\/\/doi.org\/10.5414\/CP204751","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"5252_CR72","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3892\/ijo.2017.4111","volume":"51","author":"Q Ma","year":"2017","unstructured":"Ma Q, Wu X, Wu J, Liang Z, Liu T (2017) SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB\/NF-\u03baB axis. Int J Oncol 51(4):1104\u20131114. https:\/\/doi.org\/10.3892\/ijo.2017.4111","journal-title":"Int J Oncol"},{"key":"5252_CR73","doi-asserted-by":"publisher","first-page":"1202324","DOI":"10.3389\/fimmu.2023.1202324","volume":"14","author":"H Guo","year":"2023","unstructured":"Guo H, Zhang S, Zhang B, Shang Y, Liu X, Wang M, Wang H, Fan Y, Tan K (2023) Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma. Front Immunol 14:1202324. https:\/\/doi.org\/10.3389\/fimmu.2023.1202324","journal-title":"Front Immunol"},{"issue":"15","key":"5252_CR74","doi-asserted-by":"publisher","first-page":"13823","DOI":"10.1007\/s00432-023-05202-2","volume":"149","author":"X Wang","year":"2023","unstructured":"Wang X, Chen X, Zhao M, Li G, Cai D, Yan F, Fang J (2023) Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma. J Cancer Res Clin Oncol 149(15):13823\u201313839. https:\/\/doi.org\/10.1007\/s00432-023-05202-2","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"5252_CR75","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000439589","volume":"4","author":"T Pilli","year":"2015","unstructured":"Pilli T, Cantara S, Schomburg L, Cenci V, Cardinale S, Heid EC, K\u00fchn EC, Cevenini G, Sestini F, Fioravanti C, D\u2019Hauw G, Pacini F (2015) IFN\u03b3-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 \u00b5g) versus Placebo. Eur Thyroid J 4(4):226\u2013233. https:\/\/doi.org\/10.1159\/000439589","journal-title":"Eur Thyroid J"},{"issue":"1","key":"5252_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/toxres\/tfab122","volume":"11","author":"NAE Sherif","year":"2021","unstructured":"Sherif NAE, El-Banna A, Abdel-Moneim RA, Sobh ZK, Balah MIF (2021) The possible thyroid disruptive effect of di-(2-ethyl hexyl) phthalate and the potential protective role of selenium and curcumin nanoparticles: a toxicological and histological study. Toxicol Res (Camb) 11(1):108\u2013121. https:\/\/doi.org\/10.1093\/toxres\/tfab122","journal-title":"Toxicol Res (Camb)"},{"issue":"6","key":"5252_CR77","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3923\/pjbs.2023.334.346","volume":"26","author":"AA Al-Shelash","year":"2023","unstructured":"Al-Shelash AA, Gomaa HF (2023) Prospective Effect of Nano-Selenium Particles on Thyroid Dysfunction and Oxidative Stress Induced by Sodium Benzoate in Male Albino Rats. Pak J Biol Sci 26(6):334\u2013346. https:\/\/doi.org\/10.3923\/pjbs.2023.334.346","journal-title":"Pak J Biol Sci"},{"key":"5252_CR78","doi-asserted-by":"publisher","unstructured":"Porter DJ, Raymond LW, Anastasio GD (1999 Sep-Oct) Chromium: friend or foe? Arch Fam Med. 8(5):386\u2013390. https:\/\/doi.org\/10.1001\/archfami.8.5.386","DOI":"10.1001\/archfami.8.5.386"},{"issue":"1","key":"5252_CR79","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/toxsci\/kfm081","volume":"98","author":"X He","year":"2007","unstructured":"He X, Lin GX, Chen MG, Zhang JX, Ma Q (2007) Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2\/Keap1 association. Toxicol Sci 98(1):298\u2013309. https:\/\/doi.org\/10.1093\/toxsci\/kfm081","journal-title":"Toxicol Sci"},{"issue":"2","key":"5252_CR80","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1081\/clt-100102418","volume":"37","author":"DG Barceloux","year":"1999","unstructured":"Barceloux DG, Chromium (1999) J Toxicol Clin Toxicol 37(2):173\u2013194. https:\/\/doi.org\/10.1081\/clt-100102418","journal-title":"J Toxicol Clin Toxicol"},{"key":"5252_CR81","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.biopha.2018.01.083","volume":"99","author":"HH Atteia","year":"2018","unstructured":"Atteia HH, Arafa MH, Prabahar K (2018) Selenium nanoparticles prevents lead acetate-induced hypothyroidism and oxidative damage of thyroid tissues in male rats through modulation of selenoenzymes and suppression of miR-224. Biomed Pharmacother 99:486\u2013491. https:\/\/doi.org\/10.1016\/j.biopha.2018.01.083","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5252_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/21691401.2021.1871620","volume":"49","author":"X Zou","year":"2021","unstructured":"Zou X, Jiang Z, Li L, Huang Z (2021) Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer. Artif Cells Nanomed Biotechnol 49(1):83\u201395. https:\/\/doi.org\/10.1080\/21691401.2021.1871620","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"5252_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","volume":"185","author":"A Huwiler","year":"2018","unstructured":"Huwiler A, Zangemeister-Wittke U (2018) The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives. Pharmacol Ther 185:34\u201349. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.11.001","journal-title":"Pharmacol Ther"},{"issue":"7","key":"5252_CR84","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/0008-5472.CAN-17-1423","volume":"78","author":"M Nagahashi","year":"2018","unstructured":"Nagahashi M, Yamada A, Katsuta E, Aoyagi T, Huang WC, Terracina KP, Hait NC, Allegood JC, Tsuchida J, Yuza K, Nakajima M, Abe M, Sakimura K, Milstien S, Wakai T, Spiegel S, Takabe K (2018) Targeting the SphK1\/S1P\/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis. Cancer Res 78(7):1713\u20131725. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1423","journal-title":"Cancer Res"},{"issue":"10","key":"5252_CR85","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.cellsig.2010.05.022","volume":"22","author":"F Tonelli","year":"2010","unstructured":"Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, Bittman R, Pyne S, Pyne NJ (2010) FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal 22(10):1536\u20131542. https:\/\/doi.org\/10.1016\/j.cellsig.2010.05.022","journal-title":"Cell Signal"},{"issue":"5","key":"5252_CR86","doi-asserted-by":"publisher","first-page":"599","DOI":"10.55730\/1300-0527.3756","volume":"49","author":"E Atan","year":"2025","unstructured":"Atan E, Ak G (2025) Levothyroxine combined with selenium nanoparticles in one liposomal delivery system for hypothyroidism. Turk J Chem 49(5):599\u2013608. https:\/\/doi.org\/10.55730\/1300-0527.3756","journal-title":"Turk J Chem"},{"issue":"18","key":"5252_CR87","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.7150\/thno.117582","volume":"15","author":"Y Tan","year":"2025","unstructured":"Tan Y, Zhang F, Cao J, Feng L, Xie B, Gao L, Chen X, Yan Z, Xiong W (2025) GPX1-driven selenium nanoplatform reprograms MAMs-mediated organelle crosstalk to reverse inflammatory adipose expansion in thyroid eye disease. Theranostics 15(18):9601\u20139622. https:\/\/doi.org\/10.7150\/thno.117582","journal-title":"Theranostics"},{"issue":"4","key":"5252_CR88","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/thy.2014.0300","volume":"25","author":"JS Yoon","year":"2015","unstructured":"Yoon JS, Lee HJ, Chae MK, Lee EJ (2015) Autophagy is involved in the initiation and progression of Graves\u2019 orbitopathy. Thyroid 25(4):445\u2013454. https:\/\/doi.org\/10.1089\/thy.2014.0300","journal-title":"Thyroid"},{"issue":"4","key":"5252_CR89","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1530\/JME-21-0057","volume":"66","author":"J Ko","year":"2021","unstructured":"Ko J, Kim JY, Kyoung Chae M, Jig Lee E, Sook Yoon J (2021) PERK mediates oxidative stress and adipogenesis in Graves\u2019 orbitopathy pathogenesis. J Mol Endocrinol 66(4):313\u2013323. https:\/\/doi.org\/10.1530\/JME-21-0057","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"5252_CR90","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/thy.2020.0253","volume":"31","author":"MM Fran\u00e7a","year":"2021","unstructured":"Fran\u00e7a MM, German A, Fernandes GW, Liao XH, Bianco AC, Refetoff S, Dumitrescu AM (2021) Human Type 1 Iodothyronine Deiodinase (DIO1) Mutations Cause Abnormal Thyroid Hormone Metabolism. Thyroid 31(2):202\u2013207. https:\/\/doi.org\/10.1089\/thy.2020.0253","journal-title":"Thyroid"},{"issue":"7","key":"5252_CR91","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1210\/er.2008-0019","volume":"29","author":"B Gereben","year":"2008","unstructured":"Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Ze\u00f6ld A, Bianco AC (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29(7):898\u2013938. https:\/\/doi.org\/10.1210\/er.2008-0019","journal-title":"Endocr Rev"},{"issue":"4","key":"5252_CR92","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00008480-200308000-00011","volume":"15","author":"A Hernandez","year":"2003","unstructured":"Hernandez A, St Germain DL (2003) Thyroid hormone deiodinases: physiology and clinical disorders. Curr Opin Pediatr 15(4):416\u2013420. https:\/\/doi.org\/10.1097\/00008480-200308000-00011","journal-title":"Curr Opin Pediatr"},{"issue":"10","key":"5252_CR93","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1172\/JCI29812","volume":"116","author":"AC Bianco","year":"2006","unstructured":"Bianco AC, Kim BW (2006) Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 116(10):2571\u20132579. https:\/\/doi.org\/10.1172\/JCI29812","journal-title":"J Clin Invest"},{"issue":"8","key":"5252_CR94","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1210\/jc.2008-0397","volume":"93","author":"V Panicker","year":"2008","unstructured":"Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferrucci L, Melzer D, Saravanan P, Visser TJ, Ceresini G, Hattersley AT, Vaidya B, Dayan CM, Frayling TM (2008) A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab 93(8):3075\u20133081. https:\/\/doi.org\/10.1210\/jc.2008-0397","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5252_CR95","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1507\/endocrj.EJ17-0162","volume":"65","author":"M Arici","year":"2018","unstructured":"Arici M, Oztas E, Yanar F, Aksakal N, Ozcinar B, Ozhan G (2018) Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients. Endocr J 65(3):317\u2013323. https:\/\/doi.org\/10.1507\/endocrj.EJ17-0162","journal-title":"Endocr J"},{"issue":"1","key":"5252_CR96","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12902-023-01425-z","volume":"23","author":"R AlEjielat","year":"2023","unstructured":"AlEjielat R, Khaleel A, Batarseh YS, Abu-Qatouseh L, Al-Wawi S, AlSunna T (2023) SNP rs11185644 in RXRA gene and SNP rs2235544 in DIO1 gene predict dosage requirements in a cross-sectional sample of hypothyroid patients. BMC Endocr Disord 23(1):167. https:\/\/doi.org\/10.1186\/s12902-023-01425-z","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"5252_CR97","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/thy.2020.0253","volume":"31","author":"MM Fran\u00e7a","year":"2021","unstructured":"Fran\u00e7a MM, German A, Fernandes GW, Liao XH, Bianco AC, Refetoff S, Dumitrescu AM (2021) Human Type 1 Iodothyronine Deiodinase (DIO1) Mutations Cause Abnormal Thyroid Hormone Metabolism. Thyroid 31(2):202\u2013207. https:\/\/doi.org\/10.1089\/thy.2020.0253","journal-title":"Thyroid"},{"key":"5252_CR98","doi-asserted-by":"publisher","unstructured":"Jawad EH, Hoshi B, Jubair S (2022) The role of deiodinase type 1 polymorphism, rs11206244 (C785T), in clinical management of a sample of Iraqi hypothyroidism patients treated with levothyroxine. Hum Gene 34. https:\/\/doi.org\/10.1016\/j.humgen.2022.201110","DOI":"10.1016\/j.humgen.2022.201110"},{"issue":"1","key":"5252_CR99","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1210\/en.2005-0739","volume":"147","author":"MJ Schneider","year":"2006","unstructured":"Schneider MJ, Fiering SN, Thai B, Wu SY, St Germain E, Parlow AF, St Germain DL, Galton VA (2006) Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147(1):580\u2013589. https:\/\/doi.org\/10.1210\/en.2005-0739","journal-title":"Endocrinology"},{"issue":"3","key":"5252_CR100","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/ijms25031915","volume":"25","author":"F Hanif","year":"2024","unstructured":"Hanif F, Amir Q, Washdev W (2024) Effect of DIO2 Gene Polymorphism on Thyroid Hormone Levels and Its Correlation with the Severity of Schizophrenia in a Pakistani Population. Int J Mol Sci 25(3):1915. https:\/\/doi.org\/10.3390\/ijms25031915","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5252_CR101","doi-asserted-by":"publisher","first-page":"E1527","DOI":"10.1210\/jc.2011-0235","volume":"96","author":"HC Hoftijzer","year":"2011","unstructured":"Hoftijzer HC, Heemstra KA, Visser TJ, le Cessie S, Peeters RP, Corssmit EP, Smit JW (2011) The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab 96(9):E1527\u2013E1533. https:\/\/doi.org\/10.1210\/jc.2011-0235","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5252_CR102","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12902-025-02085-x","volume":"25","author":"J Chen","year":"2025","unstructured":"Chen J, Lin Z, Luo Y, Tang H, Chen F, Liu P, Huang Y (2025) Impact of DIO2 polymorphisms on quality of life and TSH suppression therapy in patients with papillary thyroid cancer. BMC Endocr Disord 25(1):278. https:\/\/doi.org\/10.1186\/s12902-025-02085-x","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"5252_CR103","doi-asserted-by":"publisher","first-page":"10090","DOI":"10.1038\/s41598-018-28480-0","volume":"8","author":"E Park","year":"2018","unstructured":"Park E, Jung J, Araki O, Tsunekawa K, Park SY, Kim J, Murakami M, Jeong SY, Lee S (2018) Concurrent TSHR mutations and DIO2 T92A polymorphism result in abnormal thyroid hormone metabolism. Sci Rep 8(1):10090. https:\/\/doi.org\/10.1038\/s41598-018-28480-0","journal-title":"Sci Rep"},{"issue":"7","key":"5252_CR104","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1016\/j.bbagen.2012.08.019","volume":"1830","author":"E Arrojo","year":"2013","unstructured":"Arrojo E, Drigo R, Fonseca TL, Werneck-de-Castro JP, Bianco AC (2013) Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim Biophys Acta 1830(7):3956\u20133964. https:\/\/doi.org\/10.1016\/j.bbagen.2012.08.019","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"5252_CR105","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1210\/mend.15.12.0740","volume":"15","author":"MJ Schneider","year":"2001","unstructured":"Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, Galton VA (2001) Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15(12):2137\u20132148. https:\/\/doi.org\/10.1210\/mend.15.12.0740","journal-title":"Mol Endocrinol"},{"issue":"5","key":"5252_CR106","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4274\/tjps","volume":"20","author":"AH Mohmmed","year":"2023","unstructured":"Mohmmed AH, Hoshi B, Jubair S (2023) Deiodinase Type 3 Polymorphism (rs1190716) Affects Therapeutic Response to Levothyroxine. Turk J Pharm Sci 20(5):335\u2013340. https:\/\/doi.org\/10.4274\/tjps","journal-title":"Turk J Pharm Sci"},{"issue":"3","key":"5252_CR107","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ygeno.2003.08.024","volume":"83","author":"A Hernandez","year":"2004","unstructured":"Hernandez A, Martinez ME, Croteau W, St Germain DL (2004) Complex organization and structure of sense and antisense transcripts expressed from the DIO3 gene imprinted locus. Genomics 83(3):413\u2013424. https:\/\/doi.org\/10.1016\/j.ygeno.2003.08.024","journal-title":"Genomics"},{"issue":"6","key":"5252_CR108","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/ijms19061804","volume":"19","author":"A Hernandez","year":"2018","unstructured":"Hernandez A, Stohn JP (2018) The Type 3 Deiodinase: Epigenetic Control of Brain Thyroid Hormone Action and Neurological Function. Int J Mol Sci 19(6):1804. https:\/\/doi.org\/10.3390\/ijms19061804","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5252_CR109","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/cells13121001","volume":"13","author":"LF Alves","year":"2024","unstructured":"Alves LF, da Silva IN, de Mello DC, Fuziwara CS, Guil S, Esteller M, Geraldo MV (2024) Epigenetic Regulation of DLK1-DIO3 Region in Thyroid Carcinoma. Cells 13(12):1001. https:\/\/doi.org\/10.3390\/cells13121001","journal-title":"Cells"},{"issue":"1","key":"5252_CR110","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ydbio.2019.07.005","volume":"455","author":"W Zhu","year":"2019","unstructured":"Zhu W, Botticelli EM, Kery RE, Mao Y, Wang X, Yang A, Wang X, Zhou J, Zhang X, Soberman RJ, Klibanski A, Zhou Y (2019) Meg3-DMR, not the Meg3 gene, regulates imprinting of the Dlk1-Dio3 locus. Dev Biol 455(1):10\u201318. https:\/\/doi.org\/10.1016\/j.ydbio.2019.07.005","journal-title":"Dev Biol"},{"issue":"5","key":"5252_CR111","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00018-012-1080-8","volume":"70","author":"L Benetatos","year":"2013","unstructured":"Benetatos L, Hatzimichael E, Londin E, Vartholomatos G, Loher P, Rigoutsos I, Briasoulis E (2013) The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci 70(5):795\u2013814. https:\/\/doi.org\/10.1007\/s00018-012-1080-8","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"5252_CR112","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.18632\/oncotarget.14162","volume":"8","author":"MV Geraldo","year":"2017","unstructured":"Geraldo MV, Nakaya HI, Kimura ET (2017) Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer. Oncotarget 8(6):9597\u20139607. https:\/\/doi.org\/10.18632\/oncotarget.14162","journal-title":"Oncotarget"},{"issue":"2","key":"5252_CR113","doi-asserted-by":"publisher","first-page":"E196","DOI":"10.1210\/jc.2012-2666","volume":"98","author":"CK Chou","year":"2013","unstructured":"Chou CK, Yang KD, Chou FF, Huang CC, Lan YW, Lee YF, Kang HY, Liu RT (2013) Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab 98(2):E196\u2013205. https:\/\/doi.org\/10.1210\/jc.2012-2666","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"5252_CR114","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/onc.2011.381","volume":"31","author":"MV Geraldo","year":"2012","unstructured":"Geraldo MV, Yamashita AS, Kimura ET (2012) MicroRNA miR-146b-5p regulates signal transduction of TGF-\u03b2 by repressing SMAD4 in thyroid cancer. Oncogene 31(15):1910\u20131922. https:\/\/doi.org\/10.1038\/onc.2011.381","journal-title":"Oncogene"},{"key":"5252_CR115","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.freeradbiomed.2022.08.022","volume":"191","author":"L Schomburg","year":"2022","unstructured":"Schomburg L (2022) Selenoprotein P - Selenium transport protein, enzyme and biomarker of selenium status. Free Radic Biol Med 191:150\u2013163. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.08.022","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5252_CR116","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/nu12041067","volume":"12","author":"O Brodin","year":"2020","unstructured":"Brodin O, Hackler J, Misra S, Wendt S, Sun Q, Laaf E, Stoppe C, Bj\u00f6rnstedt M, Schomburg L (2020) Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite. Nutrients 12(4):1067. https:\/\/doi.org\/10.3390\/nu12041067","journal-title":"Nutrients"},{"issue":"12","key":"5252_CR117","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1210\/jc.2010-0191","volume":"95","author":"LH Duntas","year":"2010","unstructured":"Duntas LH (2010) Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 95(12):5180\u20135188. https:\/\/doi.org\/10.1210\/jc.2010-0191","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5252_CR118","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1590\/2359-3997000000309","volume":"61","author":"MAF Federige","year":"2017","unstructured":"Federige MAF, Romaldini JH, Miklos ABPP, Koike MK, Takei K, Portes ES (2017) Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study. Arch Endocrinol Metab 61(6):600\u2013607. https:\/\/doi.org\/10.1590\/2359-3997000000309","journal-title":"Arch Endocrinol Metab"},{"issue":"23","key":"5252_CR119","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.3390\/ijms222313088","volume":"22","author":"Q Sun","year":"2021","unstructured":"Sun Q, Mehl S, Renko K, Seemann P, G\u00f6rlich CL, Hackler J, Minich WB, Kahaly GJ, Schomburg L (2021) Natural Autoimmunity to Selenoprotein P Impairs Selenium Transport in Hashimoto\u2019s Thyroiditis. Int J Mol Sci 22(23):13088. https:\/\/doi.org\/10.3390\/ijms222313088","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5252_CR120","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, Angeletti D, Fiore M, D\u2019Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A (2020) Hashimoto\u2019s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev 19(10):102649. https:\/\/doi.org\/10.1016\/j.autrev.2020.102649","journal-title":"Autoimmun Rev"},{"issue":"7","key":"5252_CR121","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.autrev.2008.04.006","volume":"7","author":"CL Burek","year":"2008","unstructured":"Burek CL, Rose NR (2008) Autoimmune thyroiditis and ROS. Autoimmun Rev 7(7):530\u2013537. https:\/\/doi.org\/10.1016\/j.autrev.2008.04.006","journal-title":"Autoimmun Rev"},{"key":"5252_CR122","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jtemb.2018.04.005","volume":"48","author":"EG Varlamova","year":"2018","unstructured":"Varlamova EG (2018) Participation of selenoproteins localized in the ER in the processes occurring in this organelle and in the regulation of carcinogenesis-associated processes. J Trace Elem Med Biol 48:172\u2013180. https:\/\/doi.org\/10.1016\/j.jtemb.2018.04.005","journal-title":"J Trace Elem Med Biol"},{"key":"5252_CR123","doi-asserted-by":"publisher","unstructured":"Varlamova EG (2020 Apr-May) Protein-protein interactions of ER-resident selenoproteins with their physiological partners. Biochimie 171\u2013172:197\u2013204. https:\/\/doi.org\/10.1016\/j.biochi.2020.03.012","DOI":"10.1016\/j.biochi.2020.03.012"},{"key":"5252_CR124","doi-asserted-by":"publisher","unstructured":"Mal\u2019tseva VN, Goltyaev MV, Novoselov SV, Varlamova EG (2022) Effects of Sodium Selenite and Dithiothreitol on Expression of Endoplasmic Reticulum Selenoproteins and Apoptosis Markers in MSF7 Breast Adenocarcinoma Cells. Mol Biol (Mosk) Russian 56(1):135\u2013146. https:\/\/doi.org\/10.31857\/S0026898422010062","DOI":"10.31857\/S0026898422010062"},{"issue":"11","key":"5252_CR125","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ng1655","volume":"37","author":"JE Curran","year":"2005","unstructured":"Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Abel Azim DM, Cai G, Mahaney MC, Comuzzie AG, Dyer TD, Walder KR, Zimmet P, MacCluer JW, Collier GR, Kissebah AH, Blangero J (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37(11):1234\u20131241. https:\/\/doi.org\/10.1038\/ng1655","journal-title":"Nat Genet"},{"issue":"4","key":"5252_CR126","doi-asserted-by":"publisher","first-page":"E719","DOI":"10.1210\/jc.2013-3539","volume":"99","author":"LR Santos","year":"2014","unstructured":"Santos LR, Dur\u00e3es C, Mendes A, Prazeres H, Alvelos MI, Moreira CS, Canedo P, Esteves C, Neves C, Carvalho D, Sobrinho-Sim\u00f5es M, Soares P (2014) A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto\u2019s thyroiditis susceptibility. J Clin Endocrinol Metab 99(4):E719\u2013E723. https:\/\/doi.org\/10.1210\/jc.2013-3539","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"5252_CR127","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1089\/thy.2018.0480","volume":"29","author":"LR Santos","year":"2019","unstructured":"Santos LR, Dur\u00e3es C, Ziros PG, Pestana A, Esteves C, Neves C, Carvalho D, Bongiovanni M, Renaud CO, Chartoumpekis DV, Habeos IG, Sim\u00f5es MS, Soares P, Sykiotis GP (2019) Interaction of Genetic Variations in NFE2L2 and SELENOS Modulates the Risk of Hashimoto\u2019s Thyroiditis. Thyroid 29(9):1302\u20131315. https:\/\/doi.org\/10.1089\/thy.2018.0480","journal-title":"Thyroid"},{"key":"5252_CR128","doi-asserted-by":"publisher","first-page":"102954","DOI":"10.1016\/j.dnarep.2020.102954","volume":"95","author":"KD Arczewska","year":"2020","unstructured":"Arczewska KD, Krasuska W, Stachurska A, Karpi\u0144ska K, Sikorska J, Kiedrowski M, Lange D, St\u0119pie\u0144 T, Czarnocka B (2020) hMTH1 and GPX1 expression in human thyroid tissue is interrelated to prevent oxidative DNA damage. DNA Repair (Amst) 95:102954. https:\/\/doi.org\/10.1016\/j.dnarep.2020.102954","journal-title":"DNA Repair (Amst)"},{"key":"5252_CR129","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fendo.2019.00510","volume":"10","author":"CO Renaud","year":"2019","unstructured":"Renaud CO, Ziros PG, Chartoumpekis DV, Bongiovanni M, Sykiotis GP (2019) Keap1\/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer. Front Endocrinol (Lausanne) 10:510. https:\/\/doi.org\/10.3389\/fendo.2019.00510","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5252_CR130","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12935-018-0504-4","volume":"18","author":"A Metere","year":"2018","unstructured":"Metere A, Frezzotti F, Graves CE, Vergine M, De Luca A, Pietraforte D, Giacomelli L (2018) A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery. Cancer Cell Int 18:7. https:\/\/doi.org\/10.1186\/s12935-018-0504-4","journal-title":"Cancer Cell Int"},{"issue":"10","key":"5252_CR131","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s40618-015-0285-8","volume":"38","author":"CR de Farias","year":"2015","unstructured":"de Farias CR, Cardoso BR, de Oliveira GM, de Mello Guazzelli IC, Catarino RM, Chammas MC, Cozzolino SM, Knobel M (2015) A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J Endocrinol Invest 38(10):1065\u20131074. https:\/\/doi.org\/10.1007\/s40618-015-0285-8","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"5252_CR132","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1677\/joe.1.06661","volume":"190","author":"O Turker","year":"2006","unstructured":"Turker O, Kumanlioglu K, Karapolat I, Dogan I (2006) Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J Endocrinol 190(1):151\u2013156. https:\/\/doi.org\/10.1677\/joe.1.06661","journal-title":"J Endocrinol"},{"issue":"3","key":"5252_CR133","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1515\/raon-2016-0031","volume":"50","author":"B Krhin","year":"2016","unstructured":"Krhin B, Goricar K, Gazic B, Dolzan V, Besic N (2016) Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma. Radiol Oncol 50(3):289\u2013296. https:\/\/doi.org\/10.1515\/raon-2016-0031","journal-title":"Radiol Oncol"},{"issue":"5","key":"5252_CR134","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.surg.2008.12.008","volume":"145","author":"JC Lin","year":"2009","unstructured":"Lin JC, Kuo WR, Chiang FY, Hsiao PJ, Lee KW, Wu CW, Juo SH (2009) Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer. Surgery 145(5):508\u2013513. https:\/\/doi.org\/10.1016\/j.surg.2008.12.008","journal-title":"Surgery"},{"issue":"8","key":"5252_CR135","doi-asserted-by":"publisher","first-page":"e18489","DOI":"10.1016\/j.heliyon.2023.e18489","volume":"9","author":"D Zhang","year":"2023","unstructured":"Zhang D, Deng JJ, Xu Q, Zeng Y, Jiang J (2023) MiR-146b-5p regulates the scavenging effect of GPx-3 on peroxide in papillary thyroid cancer cells. Heliyon 9(8):e18489. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18489","journal-title":"Heliyon"},{"issue":"25","key":"5252_CR136","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41388-017-0088-9","volume":"37","author":"J Ram\u00edrez-Moya","year":"2018","unstructured":"Ram\u00edrez-Moya J, Wert-Lamas L, Santisteban P (2018) MicroRNA-146b promotes PI3K\/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Oncogene 37(25):3369\u20133383. https:\/\/doi.org\/10.1038\/s41388-017-0088-9","journal-title":"Oncogene"},{"issue":"12","key":"5252_CR137","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1089\/thy.2017.0626","volume":"28","author":"C Yu","year":"2018","unstructured":"Yu C, Zhang L, Luo D, Yan F, Liu J, Shao S, Zhao L, Jin T, Zhao J, Gao L (2018) MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting NF2 in Human Papillary Thyroid Cancer. Thyroid 28(12):1627\u20131641. https:\/\/doi.org\/10.1089\/thy.2017.0626","journal-title":"Thyroid"},{"key":"5252_CR138","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2147\/OTT.S231361","volume":"13","author":"K Jiang","year":"2020","unstructured":"Jiang K, Li G, Chen W, Song L, Wei T, Li Z, Gong R, Lei J, Shi H, Zhu J (2020) Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas. Onco Targets Ther 13:1311\u20131319. https:\/\/doi.org\/10.2147\/OTT.S231361","journal-title":"Onco Targets Ther"},{"issue":"5","key":"5252_CR139","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/15384047.2020.1721250","volume":"21","author":"A Al-Abdallah","year":"2020","unstructured":"Al-Abdallah A, Jahanbani I, Mehdawi H, Ali RH, Al-Brahim N, Mojiminiyi O (2020) The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesis. Cancer Biol Ther 21(5):412\u2013423. https:\/\/doi.org\/10.1080\/15384047.2020.1721250","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"5252_CR140","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/antiox9111070","volume":"9","author":"R Rostami","year":"2020","unstructured":"Rostami R, Nourooz-Zadeh S, Mohammadi A, Khalkhali HR, Ferns G, Nourooz-Zadeh J (2020) Serum Selenium Status and Its Interrelationship with Serum Biomarkers of Thyroid Function and Antioxidant Defense in Hashimoto\u2019s Thyroiditis. Antioxid (Basel) 9(11):1070. https:\/\/doi.org\/10.3390\/antiox9111070","journal-title":"Antioxid (Basel)"},{"issue":"6","key":"5252_CR141","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.7150\/jca.104687","volume":"16","author":"R Zhang","year":"2025","unstructured":"Zhang R, Chen Y, Xu S, Gu X, Ye H (2025) Identification of GPX3 and JUN as Tumor Suppressors in Thyroid Cancer through Integrated WGCNA and Mendelian Randomization. J Cancer 16(6):1814\u20131831. https:\/\/doi.org\/10.7150\/jca.104687","journal-title":"J Cancer"},{"issue":"10","key":"5252_CR142","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1515\/BC.2007.122","volume":"388","author":"C Schmutzler","year":"2007","unstructured":"Schmutzler C, Mentrup B, Schomburg L, Hoang-Vu C, Herzog V, K\u00f6hrle J (2007) Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol Chem 388(10):1053\u20131059. https:\/\/doi.org\/10.1515\/BC.2007.122","journal-title":"Biol Chem"},{"issue":"1","key":"5252_CR143","doi-asserted-by":"publisher","first-page":"230","DOI":"10.18632\/aging.204473","volume":"15","author":"H Chen","year":"2023","unstructured":"Chen H, Peng F, Xu J, Wang G, Zhao Y (2023) Increased expression of GPX4 promotes the tumorigenesis of thyroid cancer by inhibiting ferroptosis and predicts poor clinical outcomes. Aging 15(1):230\u2013245. https:\/\/doi.org\/10.18632\/aging.204473","journal-title":"Aging"},{"issue":"1","key":"5252_CR144","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1038\/s41598-022-23906-2","volume":"12","author":"KR Sekhar","year":"2022","unstructured":"Sekhar KR, Hanna DN, Cyr S, Baechle JJ, Kuravi S, Balusu R, Rathmell K, Baregamian N (2022) Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer. Sci Rep 12(1):19396. https:\/\/doi.org\/10.1038\/s41598-022-23906-2","journal-title":"Sci Rep"},{"issue":"12","key":"5252_CR145","doi-asserted-by":"publisher","first-page":"16500","DOI":"10.18632\/aging.203172","volume":"13","author":"W Chen","year":"2021","unstructured":"Chen W, Fu J, Chen Y, Li Y, Ning L, Huang D, Yan S, Zhang Q, Circular (2021) RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer. Aging 13(12):16500\u201316512. https:\/\/doi.org\/10.18632\/aging.203172","journal-title":"Aging"},{"issue":"4","key":"5252_CR146","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/CBM-230220","volume":"39","author":"T Dang","year":"2024","unstructured":"Dang T, Yu J, Yu Y, Jiang J, Shi Y, Yu S, Peng C, Min X, Xiong Y, Long P, Zhou W, Dai D (2024) GPX4 inhibits apoptosis of thyroid cancer cells through regulating the FKBP8\/Bcl-2 axis. Cancer Biomark 39(4):349\u2013360. https:\/\/doi.org\/10.3233\/CBM-230220","journal-title":"Cancer Biomark"},{"issue":"9","key":"5252_CR147","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/antiox10091442","volume":"10","author":"J Kochman","year":"2021","unstructured":"Kochman J, Jakubczyk K, Bargiel P, Janda-Milczarek K (2021) The Influence of Oxidative Stress on Thyroid Diseases. Antioxid (Basel) 10(9):1442. https:\/\/doi.org\/10.3390\/antiox10091442","journal-title":"Antioxid (Basel)"},{"issue":"2","key":"5252_CR148","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1210\/endo.141.2.7291","volume":"141","author":"M Vitale","year":"2000","unstructured":"Vitale M, Di Matola T, D\u2019Ascoli F, Salzano S, Bogazzi F, Fenzi G, Martino E, Rossi G (2000) Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141(2):598\u2013605. https:\/\/doi.org\/10.1210\/endo.141.2.7291","journal-title":"Endocrinology"},{"issue":"4\u20135","key":"5252_CR149","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.clinbiochem.2012.11.021","volume":"46","author":"R Rostami","year":"2013","unstructured":"Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J (2013) Enhanced oxidative stress in Hashimoto\u2019s thyroiditis: inter-relationships to biomarkers of thyroid function. Clin Biochem 46(4\u20135):308\u2013312. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.11.021","journal-title":"Clin Biochem"},{"issue":"3","key":"5252_CR150","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/ERC-18-0476","volume":"26","author":"AE Hassani","year":"2019","unstructured":"Hassani AE, Buffet R, Leboulleux C, Dupuy S (2019) Oxidative stress in thyroid carcinomas: biological and clinical significance. Endocr Relat Cancer 26(3):R131\u2013R143. https:\/\/doi.org\/10.1530\/ERC-18-0476","journal-title":"Endocr Relat Cancer"},{"issue":"27","key":"5252_CR151","doi-asserted-by":"publisher","first-page":"200903","DOI":"10.5696\/2156-9614-10.27.200903","volume":"10","author":"YA Fahim","year":"2020","unstructured":"Fahim YA, Sharaf NE, Hasani IW, Ragab EA, Abdelhakim HK (2020) Assessment of Thyroid Function and Oxidative Stress State in Foundry Workers Exposed to Lead. J Health Pollut 10(27):200903. https:\/\/doi.org\/10.5696\/2156-9614-10.27.200903","journal-title":"J Health Pollut"},{"issue":"1\u20133","key":"5252_CR152","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12011-010-8625-1","volume":"138","author":"S Lassoued","year":"2010","unstructured":"Lassoued S, Mseddi M, Mnif F, Abid M, Guermazi F, Masmoudi H, El Feki A, Attia H (2010) A comparative study of the oxidative profile in Graves\u2019 disease, Hashimoto\u2019s thyroiditis, and papillary thyroid cancer. Biol Trace Elem Res 138(1\u20133):107\u2013115. https:\/\/doi.org\/10.1007\/s12011-010-8625-1","journal-title":"Biol Trace Elem Res"},{"issue":"6","key":"5252_CR153","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/01480545.2022.2131812","volume":"46","author":"Z Najafi","year":"2023","unstructured":"Najafi Z, Chamani E, Zarban A, Rezaei Z, Sharifzadeh G (2023) The molecular evaluation of thioredoxin (TXN1 & TXN2), thioredoxin reductase 1 (TXNRd1), and oxidative stress markers in a binary rat model of hypo- and hyperthyroidism after treatment with gallic acid. Drug Chem Toxicol 46(6):1108\u20131115. https:\/\/doi.org\/10.1080\/01480545.2022.2131812","journal-title":"Drug Chem Toxicol"},{"issue":"11","key":"5252_CR154","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1210\/me.2011-0038","volume":"25","author":"SG Leoni","year":"2011","unstructured":"Leoni SG, Kimura ET, Santisteban P, De la Vieja A (2011) Regulation of thyroid oxidative state by thioredoxin reductase has a crucial role in thyroid responses to iodide excess. Mol Endocrinol 25(11):1924\u20131935. https:\/\/doi.org\/10.1210\/me.2011-0038","journal-title":"Mol Endocrinol"},{"key":"5252_CR155","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13237-019-00303-1","volume":"62","author":"A Bhattacharjee","year":"2019","unstructured":"Bhattacharjee A, Basu A, Bhattacharya S (2019) Selenium nanoparticles are less toxic than inorganic and organic selenium to mice in vivo. Nucleus 62:259\u2013268. https:\/\/doi.org\/10.1007\/s13237-019-00303-1","journal-title":"Nucleus"},{"issue":"1","key":"5252_CR156","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40104-022-00722-2","volume":"13","author":"I Bano","year":"2022","unstructured":"Bano I, Skalickova S, Arbab S, Urbankova L, Horky P (2022) Toxicological effects of nanoselenium in animals. J Anim Sci Biotechnol 13(1):72. https:\/\/doi.org\/10.1186\/s40104-022-00722-2","journal-title":"J Anim Sci Biotechnol"},{"issue":"6","key":"5252_CR157","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1007\/s12011-021-02894-w","volume":"200","author":"SE Ibrahim","year":"2022","unstructured":"Ibrahim SE, Alzawqari MH, Eid YZ, Zommara M, Hassan AM, Dawood MAO (2022) Comparing the Influences of Selenium Nanospheres, Sodium Selenite, and Biological Selenium on the Growth Performance, Blood Biochemistry, and Antioxidative Capacity of Growing Turkey Pullets. Biol Trace Elem Res 200(6):2915\u20132922. https:\/\/doi.org\/10.1007\/s12011-021-02894-w","journal-title":"Biol Trace Elem Res"},{"key":"5252_CR158","doi-asserted-by":"publisher","first-page":"127235","DOI":"10.1016\/j.jtemb.2023.127235","volume":"79","author":"N Hadrup","year":"2023","unstructured":"Hadrup N, Ravn-Haren G (2023) Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review. J Trace Elem Med Biol 79:127235. https:\/\/doi.org\/10.1016\/j.jtemb.2023.127235","journal-title":"J Trace Elem Med Biol"},{"issue":"7","key":"5252_CR159","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.3390\/ijms24076068","volume":"24","author":"A Au","year":"2023","unstructured":"Au A, Mojadadi A, Shao JY, Ahmad G, Witting PK (2023) Physiological Benefits of Novel Selenium Delivery via Nanoparticles. Int J Mol Sci 24(7):6068. https:\/\/doi.org\/10.3390\/ijms24076068","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5252_CR160","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s12011-023-03719-8","volume":"202","author":"A Darmawan","year":"2024","unstructured":"Darmawan A, Rohman M, Fitri H, Junaidi A, Rusli RK, Ozturk E (2024) A Meta-analysis of Optimum Level of Dietary Nanoselenium on Performances, Blood Constituents, Antioxidant Activity, Carcass, and Giblet Weight of Broiler Chickens. Biol Trace Elem Res 202(3):1174\u20131186. https:\/\/doi.org\/10.1007\/s12011-023-03719-8","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"5252_CR161","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s11033-024-09598-z","volume":"51","author":"JA Ansari","year":"2024","unstructured":"Ansari JA, Malik JA, Ahmed S, Manzoor M, Ahemad N, Anwar S (2024) Recent advances in the therapeutic applications of selenium nanoparticles. Mol Biol Rep 51(1):688. https:\/\/doi.org\/10.1007\/s11033-024-09598-z","journal-title":"Mol Biol Rep"},{"issue":"2","key":"5252_CR162","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/1061186X.2024.2412142","volume":"33","author":"MA Waqar","year":"2025","unstructured":"Waqar MA (2025) A comprehensive review on recent advancements in drug delivery via selenium nanoparticles. J Drug Target 33(2):157\u2013170. https:\/\/doi.org\/10.1080\/1061186X.2024.2412142","journal-title":"J Drug Target"},{"key":"5252_CR163","doi-asserted-by":"publisher","first-page":"122359","DOI":"10.1016\/j.biomaterials.2023.122359","volume":"302","author":"J Wang","year":"2023","unstructured":"Wang J, Wang Z, Li Y, Hou Y, Yin C, Yang E, Liao Z, Fan C, Martin LL, Sun D (2023) Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer\u2019s disease. Biomaterials 302:122359. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122359","journal-title":"Biomaterials"},{"key":"5252_CR164","doi-asserted-by":"publisher","first-page":"1183487","DOI":"10.3389\/fnut.2023.1183487","volume":"10","author":"T Zhang","year":"2023","unstructured":"Zhang T, Qi M, Wu Q, Xiang P, Tang D, Li Q (2023) Recent research progress on the synthesis and biological effects of selenium nanoparticles. Front Nutr 10:1183487. https:\/\/doi.org\/10.3389\/fnut.2023.1183487","journal-title":"Front Nutr"},{"issue":"12","key":"5252_CR165","doi-asserted-by":"publisher","first-page":"6466","DOI":"10.1007\/s12011-025-04653-7","volume":"203","author":"I Bano","year":"2025","unstructured":"Bano I, Hassan MF, Kieliszek M (2025) A Comprehensive Review of Selenium as a Key Regulator in Thyroid Health. Biol Trace Elem Res 203(12):6466\u20136480. https:\/\/doi.org\/10.1007\/s12011-025-04653-7","journal-title":"Biol Trace Elem Res"},{"key":"5252_CR166","doi-asserted-by":"publisher","first-page":"1133000","DOI":"10.3389\/fendo.2023.1133000","volume":"14","author":"F Wang","year":"2023","unstructured":"Wang F, Li C, Li S, Cui L, Zhao J, Liao L (2023) Selenium and thyroid diseases. Front Endocrinol (Lausanne) 14:1133000. https:\/\/doi.org\/10.3389\/fendo.2023.1133000","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5252_CR167","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2147\/IJN.S42736","volume":"8","author":"KM Hassanin","year":"2013","unstructured":"Hassanin KM, Abd El-Kawi SH, Hashem KS (2013) The prospective protective effect of selenium nanoparticles against chromium-induced oxidative and cellular damage in rat thyroid. Int J Nanomed 8:1713\u20131720. https:\/\/doi.org\/10.2147\/IJN.S42736","journal-title":"Int J Nanomed"},{"issue":"12","key":"5252_CR168","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/pharmaceutics17121556","volume":"17","author":"AN Shirazi","year":"2025","unstructured":"Shirazi AN, Vadlapatla R, Koomer A, Yep K, Parang K (2025) Selenium Nanoparticles as Versatile Delivery Tools. Pharmaceutics 17(12):1556. https:\/\/doi.org\/10.3390\/pharmaceutics17121556","journal-title":"Pharmaceutics"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05252-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05252-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05252-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:01:13Z","timestamp":1790488873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-026-05252-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":168,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5252"],"URL":"https:\/\/doi.org\/10.1007\/s12011-026-05252-w","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}